Literature DB >> 10926340

A study to investigate the ability of subjects with chronic lung diseases to provide evidential breath samples using the Lion Intoxilyzer 6000 UK breath alcohol testing device.

D Honeybourne1, A J Moore, A K Butterfield, L Azzan.   

Abstract

The Lion Intoximeter 3000 has been used for evidential breath testing in the U.K. for some years. Some individuals with lung diseases have difficulty in providing evidential breath samples using the device. This study describes an investigation that we have carried out on a newer instrument--the Lion Intoxilyzer 6000UK--which is now in use in the U.K. The study was designed to investigate the ability of subjects with a variety of lung diseases to provide evidential breath samples using this device. The 40 adult subjects investigated comprized 10 normal controls, 10 with asthma, 10 with chronic obstructive pulmonary disease (COPD) and 10 with restrictive lung disease. After baseline spirometry, subjects were given alcohol to drink, the quantity based upon body weight. After a gap of at least 20 min, subjects were asked to provide evidential breath samples in accordance with.the test procedure built into the Lion Intoxilyzer 6000UK. The results showed that two asthmatic subjects, four with COPD and three with restrictive lung disease failed to provide evidential breath samples even after four attempts. Despite the device requiring a minimum sample volume of 1.2 l, eight of the nine subjects who failed had a forced vital capacity (FVC) of more than 1.5 l. Seven of these nine subjects had a forced expiratory volume in 1 sec (FEV1) of less than 1.0 l. In conclusion, this study has shown that some subjects with lung diseases may have difficulty in providing evidential breath samples using the Lion Intoxilyzer 6000 UK.

Entities:  

Mesh:

Year:  2000        PMID: 10926340     DOI: 10.1053/rmed.2000.0797

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

Review 1.  Alcohol and airways function in health and disease.

Authors:  Joseph H Sisson
Journal:  Alcohol       Date:  2007-08-30       Impact factor: 2.405

2.  Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.

Authors:  Chengjian Tu; Manoj Jacob Mammen; Jun Li; Xiaomeng Shen; Xiaosheng Jiang; Qiang Hu; Jianmin Wang; Sanjay Sethi; Jun Qu
Journal:  J Proteome Res       Date:  2013-12-02       Impact factor: 4.466

3.  Alcohol at bedtime induces minor changes in sleep stages and blood gases in stable chronic obstructive pulmonary disease.

Authors:  Nils Henrik Holmedahl; Britt Øverland; Ove Fondenes; Ivar Ellingsen; Jon Andrew Hardie
Journal:  Sleep Breath       Date:  2014-06-17       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.